Date Range
toReport Types
Condition
See all (10)
Region of the Body
See all (10)
Specialties
See all (14)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
No Improvement in Treatment Success with Teriparatide Use for Hip and Pelvic Bone Fractures
Hip Pelvis. 2020 01-Dec;():. DOI: 10.5371/hp.2020.32.4.182
Similar Outcomes With Native Vitamin D and Eldecalcitol in Osteoporotic Women Taking Denosumab
Prog Rehabil Med. 2020 October 30,2020;():. 10.2490/prm.20200026
Teriparatide Superior to Bisphosphonates for Fracture Incidence in Post-Menopausal Osteoporosis
Medicine. 2020 01-Apr;():. 10.1097/MD.0000000000018964
No reduction in surgical time or radiation exposure with new vertebral access devices in kyphoplasty
Arch Orthop Trauma Surg. 2019 Nov;139(11):1571-1577.
Better clinicoradiological results at 3 years with SpineJack vertebral augmentation vs BPK for VCFs
Osteoporos Int. 2019 Mar;30(3):637-645. doi: 10.1007/s00198-018-4773-5
Lower risk of cement leakage with unilateral vs. bilateral vertebral augmentation for OVCFs
World Neurosurg. 2019 Feb;122:342-348. doi: 10.1016/j.wneu.2018.10.143
Rigid- vs. soft thoracolumbosacral orthosis following osteoporotic vertebral compression fracture
J Clin Med. 2019 Feb 6;8(2). pii: E198. doi: 10.3390/jcm8020198
Adherence to weekly oral BP therapy versus quarterly IV BP therapy at varying health literacy level
J Bone Miner Metab. 2018 Sep;36(5):589-595. doi: 10.1007/s00774-017-0867-y
Incidence of falls reduced following balance training in patients with osteoporosis
J Rehabil Med. 2018 Jul 17;50(7):577-581. doi: 10.2340/16501977-2334
Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis
Climacteric. 2018 Apr;21(2):189-195
Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls
Expert Opin Drug Saf. 2018 Apr;17(4):413-428
Zoledronic Acid, alendronate, and risedronate reduce vertebral, nonvertebral, and hip fracture
Osteoporos Int. 2016 Nov;27(11):3289-3300
Effects of teriparatide versus risedronate following pertrochanteric fracture fixation
J Bone Joint Surg Am. 2016 Nov 16;98(22):1868-1878
Lower incidence of vertebral fracture with romosozumab vs placebo for osteoporosis
N Engl J Med. 2016 Oct 20;375(16):1532-1543
Efficacy of vertebroplasty vs sham for acute vertebral fracture in patients over 60
Lancet. 2016 Oct 1;388(10052):1408-1416
The effect of eldecalcitol on balence and strength in women with osteoporosis
J Bone Miner Metab. 2016 Sep;34(5):547-54
Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates
J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70
Combination therapy improves site-specific BMD vs. teriparatide & denosumab monotherapies
J Clin Densitom. 2016 Jul-Sep;19(3):346-51